BIOS Option Care Health Inc

Option Care Health to Announce Third Quarter 2019 Financial Results and Host Conference Call

Option Care Health to Announce Third Quarter 2019 Financial Results and Host Conference Call

BANNOCKBURN, Ill., Oct. 16, 2019 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent national provider of home and alternate site infusion services, today announced that the Company will release results for its third quarter ended September 30, 2019 on Wednesday, November 6, 2019 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Conference Call Details

The conference call can be accessed by dialing (866) 360-3136 for U.S. participants, or (602) 563-8603 for international participants, and referencing conference ID 9661889; or via a live audio webcast that will be available online at . A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Option Care Health

At Option Care Health, Inc. (Option Care Health) (NASDAQ: BIOS), we are the largest independent home and alternate site infusion services provider in the United States. With over 6,000 teammates, including 2,900 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and employees. To learn more, please visit our website at .

For Investor Inquiries:

Bob East, Asher Dewhurst, Jordan Kohnstam

Westwicke

443-213-0500



EN
16/10/2019

Underlying

BIOSOption Care Health Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Option Care Health Inc

 PRESS RELEASE
Free
BIOS Option Care Hea...

Option Care Health to Announce Third Quarter 2019 Financial Results an...

Option Care Health to Announce Third Quarter 2019 Financial Results and Host Conference Call BANNOCKBURN, Ill., Oct. 16, 2019 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent national provider of home and alternate site infusion services, today announced that the Company will release results for its third quarter ended September 30, 2019 on Wednesday, November 6, 2019 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details ...

October 16, 2019 1 EN
 PRESS RELEASE
Free
BIOS Option Care Hea...

BioScrip Announces Shareholder Approval of Merger with Option Care

BioScrip Announces Shareholder Approval of Merger with Option Care DENVER, Aug. 02, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the “Company”), the largest independent national provider of infusion and home care management solutions, today announced that its stockholders approved the proposals that are conditions to the proposed merger with Option Care at the Company’s special meeting of stockholders held earlier today.  BioScrip’s merger with Option Care is expected to close on or about August 6, 2019. About BioScrip, Inc. BioScrip, Inc. is the largest ...

August 2, 2019 1 EN
 PRESS RELEASE
Free
BIOS Option Care Hea...

BioScrip Reports Second Quarter 2019 Financial Results

BioScrip Reports Second Quarter 2019 Financial Results DENVER, July 30, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its second quarter 2019 financial results. Second Quarter 2019 BioScrip Highlights Net revenue of $191.5 million, up 8.9% compared to $175.8 million in the second quarter of 2018.Gross revenue1 of $196.8 million, up 13.1% compared to $174.0 million in the prior year quarter.Net loss from continuing operations of $14.2 million, ...

July 30, 2019 1 EN
 PRESS RELEASE
Free
BIOS Option Care Hea...

Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recomme...

Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend that BioScrip Stockholders Vote “FOR” the Transaction Proposals in Connection with the Proposed Merger with Option Care DENVER, July 22, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip"), the largest independent national provider of infusion and home care management solutions, today announced that Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co. (“Glass Lewis”), leading independent proxy advisory firms, recommend that BioScrip stockholders vote “FOR” the proposals that are cond...

July 22, 2019 1 EN
Free Trial
BIOS Option Care Hea...

Increased risk weighs on BIOSCRIP INCO., penalising its rating down t...

The independent financial analyst theScreener just lowered the general evaluation of BIOSCRIP INCO. (US), active in the Health Care Providers industry. As regards its fundamental valuation, the title still shows 3 out of 4 possible stars. Its market behaviour, however, has slightly deteriorated and will be qualified as risky moving forward. theScreener considers that these new qualifications justify an overall rating downgrade to Slightly Negative. As of the analysis date June 14, 2019, the clos...

BIOS OPTION CARE HEALTH INC
06/15/19 June 15, 2019 6 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch